OCTRI KL2 Opportunity
The letter of intent deadline for the 2014 OCTRI KL2 opportunity has passed. Applicants will be notified if they are to submit a full application.
This opportunity is designed to support the research training and career development of investigators to conduct interdisciplinary research with scientists from diverse disciplines for a maximum of two years. All research proposed for this program must involve either clinical or translational research defined as research with human subjects or populations or with direct application to human health. At the end of this two year KL2 appointment, the scholar is expected to apply for an independent career development award, such as a K award from NIH or independent funding such as a R01.
- KL2 Scholar Support
- Selection Criteria
- Key Dates
- Letter of Intent Submission
- Complete RFA
OCTRI KL2 Scholar Support
- At least 75% of the scholar's salary annually (not to exceed a cap of $75,000 plus OPE) for 2 years. It is expected that the scholar's department will provide additional salary support if the overall salary exceeds $100,000.
- A commitment of 75% FTE to research and career development for 2 years.
- $25,000 per year in research and travel funds.
- Tuition-waiver for courses in the Human Investigations Program, including the Master of Clinical Research or Certificate in Human Investigation tracks. Courses or conferences outside of this program should be paid from research funds.
- Participation in OCTRI-supported networking and mentoring activities such as offered by the OCTRI Scholars Program.
- Access to a multidisciplinary pool of highly qualified mentors through the OCTRI Design Studio, who will guide research projects and career development.
- Priority support from OCTRI cores and services.
Applicants must meet all the following requirements for the OCTRI KL2 award:
- U.S. Citizen or Permanent Resident. Individuals with temporary or student visas are not eligible
- Hold a clinical doctorate (e.g. MD/DO, DMD/DDS, DNS, PharmD, ND, OD, DC) or a research doctorate (PhD) and have a current or pending primary faculty appointment at OHSU as an Assistant Professor level or equivalent. Clinicians must have completed specialty or subspecialty training by the time of the award.
- No prior funding as principal investigator on an NIH research grant, including an R01 or any K series grant; or PI of a subproject of a program project grant (P01), center grant (P50, P60, U54); or other equivalent grant awards. Candidates are eligible if they have been supported by an NRSA grant (F or T) or an NIH small grant (R03 or R21).
- KL2 applicants may not simultaneously submit or have pending an application for any other PHS mentored career development award (e.g. K07, K08, K22, or K23) that duplicates the provisions of the KL2 program.
Selection CriteriaA KL2 selection committee will follow the model of the NIH peer review process for K awards. Selection criteria will focus on the strengths and potential of the candidate to become a leading multidisciplinary investigator judged in five major domains:
- Potential of the Applicant: potential to conduct multidisciplinary research judging by research expertise and prior training; publications; prior participation in research.
- Research Plan: Scientific value, potential clinical importance, and feasibility of the written multidisciplinary research plan
- Training Plan: Quality, appropriateness, and composition of the multidisciplinary team of the proposed mentors; plan to gain didactic and other training at OHSU or elsewhere
- Mentors: Tangible commitment and resources provided by the home department, including protected research time, and suitability of the available clinical and laboratory infrastructure and multidisciplinary team
- Career Potential: Global assessment of the likelihood that the candidate will develop a career as an outstanding independent investigator and conduct research that will have an important impact on health. Individuals from underrepresented groups in research (women, ethnic minorities, and the disabled) are encouraged to apply. Special consideration will be given to individuals in disciplines traditionally under-represented in clinical and translational research.
|RFA released||Friday, November 22, 2013|
|Letter of Intent deadline
||Extended: Monday, January 27, 2014|
|Notification of full application invitees
||Wednesday, February 5, 2014|
|Full application deadline
||Extended: Monday, March 24, 2014|
|Notification of invitation to present
||Thursday, May 1, 2014|
|Presentation to selection committee
||Monday, May 12, 2014
|Notification of award
||Prior to July 1, 2014|
Letter of Intent Submission
The letter of intent and a biosketch in NIH format are required of all applicants and will be used to determine which applicants will be invited to submit a full application.
Letters of intent must address the following areas and questions:
- Research question to be investigated
- Preliminary data, if any
- Brief summary of the scientific plan
- Brief details of educational and training plan
- Proposed mentor team and primary mentor
Please refer to the complete RFA for specific information regarding page limitations and formatting for the letter of intent.
Submit the letter of intent and a biosketch in NIH format via the online application linked below. You will be asked to complete some demographic information before uploading documents.
Online LOI submission is now closed.
The complete RFA includes additional details about the submission process, eligibility, and firstname.lastname@example.org) or Cynthia Morris (email@example.com).